Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1,568,425
-
Shares change
-
+798,824
-
Total reported value, excl. options
-
$1,692,000
-
Value change
-
+$856,257
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$1.08
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2017
13 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2017.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,568,425 shares
of 113,177,462 outstanding shares and own 1.39% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (486,491 shares), VANGUARD GROUP INC (330,689 shares), RENAISSANCE TECHNOLOGIES LLC (299,000 shares), Park West Asset Management LLC (200,000 shares), Virtu KCG Holdings LLC (114,507 shares), GRT CAPITAL PARTNERS L.L.C. (85,570 shares), GEODE CAPITAL MANAGEMENT, LLC (31,264 shares), NORTHERN TRUST CORP (16,962 shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1,989 shares), and REILLY FINANCIAL ADVISORS, LLC (1,250 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.